BACKGROUND: Non-remission rates to pharmacotherapy for anxiety disorders are related
to higher relapse rates, decreased quality of life and greater functional impairment. Here we …

Currently there is no universally accepted definition of remission in anxiety disorders. This
may be causing significantly different estimates of treatment efficacy across anxiety …

Cognitive-behavioral therapy (CBT) is a first-line treatment for anxiety and related disorders,
with large pre-to post-treatment effect sizes. Rates of relapse, or the likelihood that a state of …

In order to examine the benefit of adding pharmacotherapy to cognitive-behavioral therapy
(CBT) for anxiety disorders, we searched for studies comparing CBT plus pharmacotherapy …

BACKGROUND: Few clinical trials of cognitive behaviour therapy (CBT) for anxiety
disorders have conducted follow-up beyond one year post-treatment. This paper …

Background Many patients with anxiety disorders remain symptomatic after receiving
evidence‐based treatment, yet research on treatment‐resistant anxiety is limited. We …

Cognitive behavioural therapy (CBT) is an effective psychological treatment for anxiety-
related disorders (anxiety disorders, post-traumatic stress disorder, and obsessive …

Background Depression and anxiety disorders are relapse-prone conditions, even after
successful treatment with pharmacotherapy or psychotherapy. Cognitive behavioural …

To our knowledge, no previous meta-analysis has attempted to compare the efficacy of
pharmacological, psychological and combined treatments for the three main anxiety …

The efficacy of cognitive-behavioral therapy (CBT) is well established in the treatment of
anxiety and depressive disorders. Meta-analyses of controlled trials indicates a moderate …